Literature DB >> 17688459

Neuropsychological functioning in euthymic bipolar disorder: a meta-analysis.

I J Torres1, V G Boudreau, L N Yatham.   

Abstract

OBJECTIVE: Although cognitive deficits are prominent in symptomatic patients with bipolar disorder, the extent and pattern of cognitive impairment in euthymic patients remain uncertain.
METHOD: Neuropsychological studies comparing euthymic bipolar patients and healthy controls were evaluated. Across studies, effect sizes reflecting patient-control differences in task performance were computed for the 15 most frequently studied cognitive measures in the literature.
RESULTS: Across the broad cognitive domains of attention/processing speed, episodic memory, and executive functioning, medium-to-large performance effect size differences were consistently observed between patients and controls, favoring the latter. Deficits were not observed on measures of vocabulary and premorbid IQ.
CONCLUSION: Meta-analytic findings provide evidence of a trait-related neuropsychological deficit in bipolar disorder involving attention/processing speed, memory, and executive function. Findings are discussed with regard to potential moderators, etiologic considerations, limitations, and future directions in neuropsychological research on bipolar disorder.

Entities:  

Mesh:

Year:  2007        PMID: 17688459     DOI: 10.1111/j.1600-0447.2007.01055.x

Source DB:  PubMed          Journal:  Acta Psychiatr Scand Suppl        ISSN: 0065-1591


  136 in total

1.  Dissociable and common deficits in inhibitory control in schizophrenia and bipolar disorder.

Authors:  Tessa Christodoulou; Lambros Messinis; Panagiotis Papathanasopoulos; Sophia Frangou
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2011-04-22       Impact factor: 5.270

Review 2.  Staging bipolar disorder.

Authors:  Eduard Vieta; M Reinares; A R Rosa
Journal:  Neurotox Res       Date:  2010-05-12       Impact factor: 3.911

Review 3.  Bipolar Depression and Cognitive Impairment: Shared Mechanisms and New Treatment Avenues.

Authors:  Colin A Depp; Sheena Dev; Lisa T Eyler
Journal:  Psychiatr Clin North Am       Date:  2015-12-11

4.  Affective temperaments and neurocognitive functioning in bipolar disorder.

Authors:  Manuela Russo; Katie Mahon; Megan Shanahan; Elizabeth Ramjas; Carly Solon; Raphael J Braga; Katherine E Burdick
Journal:  J Affect Disord       Date:  2014-08-05       Impact factor: 4.839

5.  Impulsivity in bipolar disorder: relationships with neurocognitive dysfunction and substance use history.

Authors:  Robyn L Powers; Manuela Russo; Katie Mahon; Jesse Brand; Raphael J Braga; Anil K Malhotra; Katherine E Burdick
Journal:  Bipolar Disord       Date:  2013-09-13       Impact factor: 6.744

6.  Assessing cognitive function in bipolar disorder: challenges and recommendations for clinical trial design.

Authors:  Katherine E Burdick; Terence A Ketter; Joseph F Goldberg; Joseph R Calabrese
Journal:  J Clin Psychiatry       Date:  2015-03       Impact factor: 4.384

7.  Attentional deficits and emotional bias in bipolar disorders: comparison at different stages of the disease.

Authors:  S Montel; J Scott; M Dubois; K M'bailara; C Henry
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2013-12-14       Impact factor: 5.270

8.  Neurocognitive impairment in unaffected siblings of youth with bipolar disorder.

Authors:  A E Doyle; J Wozniak; T E Wilens; A Henin; L J Seidman; C Petty; R Fried; L M Gross; S V Faraone; J Biederman
Journal:  Psychol Med       Date:  2008-12-11       Impact factor: 7.723

9.  Clinical implications of cognitive function in bipolar disorder.

Authors:  C T Sudhir Kumar; Sophia Frangou
Journal:  Ther Adv Chronic Dis       Date:  2010-05       Impact factor: 5.091

10.  Two-year course of cognitive function and instrumental activities of daily living in older adults with bipolar disorder: evidence for neuroprogression?

Authors:  A G Gildengers; D Chisholm; M A Butters; S J Anderson; A Begley; M Holm; J C Rogers; C F Reynolds; B H Mulsant
Journal:  Psychol Med       Date:  2012-07-30       Impact factor: 7.723

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.